Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
- PMID: 35328489
- PMCID: PMC8955888
- DOI: 10.3390/ijms23063068
Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
Abstract
Human neurohormone vasopressin (AVP) is synthesized in overlapping regions in the hypothalamus. It is mainly known for its vasoconstricting abilities, and it is responsible for the regulation of plasma osmolality by maintaining fluid homeostasis. Over years, many attempts have been made to modify this hormone and find AVP analogues with different pharmacological profiles that could overcome its limitations. Non-peptide AVP analogues with low molecular weight presented good affinity to AVP receptors. Natural peptide counterparts, found in animals, are successfully applied as therapeutics; for instance, lypressin used in treatment of diabetes insipidus. Synthetic peptide analogues compensate for the shortcomings of AVP. Desmopressin is more resistant to proteolysis and presents mainly antidiuretic effects, while terlipressin is a long-acting AVP analogue and a drug recommended in the treatment of varicose bleeding in patients with liver cirrhosis. Recently published results on diverse applications of AVP analogues in medicinal practice, including potential lypressin, terlipressin and ornipressin in the treatment of SARS-CoV-2, are discussed.
Keywords: desmopressin; vasoconstrictors; vasopressin; vasopressin analogues; vasopressin receptors.
Conflict of interest statement
The authors declare no conflict of interest.
Figures










Similar articles
-
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.Prog Brain Res. 2008;170:473-512. doi: 10.1016/S0079-6123(08)00437-8. Prog Brain Res. 2008. PMID: 18655903 Review.
-
Diabetes insipidus: clinical and basic aspects.Pediatr Endocrinol Rev. 2006 Dec;4 Suppl 1:60-5. Pediatr Endocrinol Rev. 2006. PMID: 17261971 Review.
-
Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.Acta Med Acad Sci Hung. 1975;32(1):75-84. Acta Med Acad Sci Hung. 1975. PMID: 1233863
-
Identification of novel selective V2 receptor non-peptide agonists.Biochem Pharmacol. 2008 Oct 30;76(9):1134-41. doi: 10.1016/j.bcp.2008.08.004. Epub 2008 Aug 12. Biochem Pharmacol. 2008. PMID: 18761325
-
Clinical review: Vasopressin and terlipressin in septic shock patients.Crit Care. 2005 Apr;9(2):212-22. doi: 10.1186/cc2945. Epub 2004 Sep 9. Crit Care. 2005. PMID: 15774080 Free PMC article. Review.
Cited by
-
Duloxetine-Induced Antidiuresis in Rats with Lithium-Induced Nephrogenic Diabetes Insipidus.Life (Basel). 2024 Aug 15;14(8):1012. doi: 10.3390/life14081012. Life (Basel). 2024. PMID: 39202754 Free PMC article.
-
Post-Transplant Hypotension in Kidney Recipients-Vasopressin to the Rescue?Kidney Int Rep. 2022 May 7;7(6):1161-1164. doi: 10.1016/j.ekir.2022.05.001. eCollection 2022 Jun. Kidney Int Rep. 2022. PMID: 35694559 Free PMC article. No abstract available.
-
OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pressure in Rat Models of Portal Hypertension.J Exp Pharmacol. 2023 Jul 13;15:279-290. doi: 10.2147/JEP.S416673. eCollection 2023. J Exp Pharmacol. 2023. PMID: 37469992 Free PMC article.
-
The role of copeptin in kidney disease.Endocrine. 2023 Mar;79(3):420-429. doi: 10.1007/s12020-022-03219-0. Epub 2022 Oct 15. Endocrine. 2023. PMID: 36242751 Review.
-
Arginine vasopressin and copeptin: comparative review and perspective in veterinary medicine.Front Vet Sci. 2025 Mar 14;12:1528008. doi: 10.3389/fvets.2025.1528008. eCollection 2025. Front Vet Sci. 2025. PMID: 40160705 Free PMC article. Review.
References
-
- Grauer A., König B. Peptidomimetics—A versatile route to biologically active compounds. Eur. J. Org. Chem. 2009;30:5099–5111. doi: 10.1002/ejoc.200900599. - DOI
-
- Vaisman A., Lushchak O. Encyclopedia of Biomedical Gerontology, Reference Modul in Biomedical Science. 1st ed. Elsevier Inc. Academic Press; Aalborg, Denmark: 2020. Geroscience; pp. 154–159. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous